Deepti Parashar

20-A, Dr. Ambedkar Road
Pune, MH 411001, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Zeolitic imidazolate frameworks for delivery of repurposed drugs with anti-chikungunya activity.

Zeolitic imidazolate frameworks for delivery of repurposed drugs with anti-chikungunya activity.

Journal: Journal of pharmaceutical sciences

Published: January 14, 2026

Antiviral Potential of Onosma bracteata Against Chikungunya Virus: Experimental Validation and Computational Mechanistic Study.

Antiviral Potential of Onosma bracteata Against Chikungunya Virus: Experimental Validation and Computational Mechanistic Study.

Journal: Applied biochemistry and biotechnology

Published: December 28, 2025

Dysbiosis of the oropharyngeal microbiota in COVID-19: distinct profiles in patients with severe respiratory symptoms.

Dysbiosis of the oropharyngeal microbiota in COVID-19: distinct profiles in patients with severe respiratory symptoms.

Journal: Journal of oral microbiology

Published: October 20, 2025

TGF-β inhibitor SB431542 suppresses SARS-CoV-2 replication through multistep inhibition.

TGF-β inhibitor SB431542 suppresses SARS-CoV-2 replication through multistep inhibition.

Journal: Journal of virology

Published: August 29, 2025

Effectiveness of 3-amino-2-thiocyanato-α, β-unsaturated carbonyl compounds against chikungunya virus.

Effectiveness of 3-amino-2-thiocyanato-α, β-unsaturated carbonyl compounds against chikungunya virus.

Journal: Future medicinal chemistry

Published: June 13, 2025

Anti-chikungunya Activity of a Cinnamic Acid Derivative: An In Vitro and In Silico Study.

Anti-chikungunya Activity of a Cinnamic Acid Derivative: An In Vitro and In Silico Study.

Journal: Molecular biotechnology

Published: December 19, 2024

Novel α-mangostin derivatives as promising antiviral agents: Isolation, synthesis, and evaluation against chikungunya virus.

Novel α-mangostin derivatives as promising antiviral agents: Isolation, synthesis, and evaluation against chikungunya virus.

Journal: European journal of medicinal chemistry

Published: September 25, 2024

RNAi-Induced Gene Silencing against Chikungunya and COVID-19: What Have We Learned So Far, and What Is the Way Forward?

RNAi-Induced Gene Silencing against Chikungunya and COVID-19: What Have We Learned So Far, and What Is the Way Forward?

Journal: Viruses

Published: July 19, 2024

Phytochemicals of Different Medicinal Herbs as Potential Inhibitors Against Dengue Serotype 2 Virus: A Computational Approach.

Phytochemicals of Different Medicinal Herbs as Potential Inhibitors Against Dengue Serotype 2 Virus: A Computational Approach.

Journal: Molecular biotechnology

Published: July 19, 2024

Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics.

Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics.

Journal: Frontiers in cellular and infection microbiology

Published: November 08, 2023

Arctigenin from Arctium lappa L. inhibits chikungunya virus by affecting its entry and replication.

Arctigenin from Arctium lappa L. inhibits chikungunya virus by affecting its entry and replication.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: October 23, 2023

Synthesis of novel rhodamine type Anthrone Spiro-lactam (ASL) analogues and evaluation of antiviral activity against dengue and chikungunya viruses.

Synthesis of novel rhodamine type Anthrone Spiro-lactam (ASL) analogues and evaluation of antiviral activity against dengue and chikungunya viruses.

Journal: European journal of medicinal chemistry

Published: August 22, 2023

Showing 1-12 of 55

Last Updated: 09/26/2026